Novartis and Nordic complete enrollment in phase III study of oral calcitonin in osteoarthritis June 5, 2009
Raptor initiates dosing in phase IIb clinical trial of DR Cysteamine in nephropathic cystinosis June 5, 2009
GlaxoSmithKline claims novel stearoyl-CoA desaturase inhibitors for the treatment of obesity June 5, 2009
Theratechnologies files NDA with FDA for tesamorelin for HIV patients with lipodystrophy June 3, 2009
Novel 11beta-hydroxysteroid dehydrogenase type 1 inhibitors claimed by AstraZeneca as antidiabetics June 3, 2009
RSS